Spriogen granted Roche's Genentech exclusive rights to develop and commercialize antibody drug conjugate products discovered using Spirogen's pyrrolobenzodiazepine antibiotics and linker technology

Spirogen Ltd.

U.K. / Private Biopharma

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Genentech Inc.

U.S. / Large-Cap Biopharma (>=$50 billion)

$98,687.2m on 03/20/2009 [market cap]

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Roche

Switzerland / Large-Cap Biopharma (>=$50 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced